id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
EPA_FRDOC_0001-30344,EPA,EPA_FRDOC_0001,"Environmental Impact Statements; Availability, etc.",Notice,,2023-12-29T05:00:00Z,2023,12,2023-12-29T05:00:00Z,,2023-12-29T13:38:49Z,2023-28749,0,0,0900006486365be4
EPA-HQ-OPP-2023-0597-0001,EPA,EPA-HQ-OPP-2023-0597,Exemption: Clothianidin,Notice,,2023-12-29T05:00:00Z,2023,12,2023-12-29T05:00:00Z,2024-01-17T04:59:59Z,2024-01-17T02:01:01Z,2023-28772,0,0,0900006486365b43
EPA-HQ-ORD-2012-0830-0100,EPA,EPA-HQ-ORD-2012-0830,Availability of the Benchmark Dose (BMD) Model Code and BMD Modeling Output Files for the Draft Integrated Risk Information System (IRIS) Toxicological Review of Inorganic Arsenic,Notice,,2023-12-29T05:00:00Z,2023,12,2023-12-29T05:00:00Z,2024-01-17T04:59:59Z,2024-01-18T02:00:45Z,2023-28766,0,0,0900006486365bde
FWS-R8-ES-2023-0191-0001,FWS,FWS-R8-ES-2023-0191,"Draft Habitat Conservation Plan and Draft Environmental Assessment; Sacramento Municipal Utility District Operations, Maintenance, and New Construction Habitat Conservation Plan, Sacramento County, CA",Notice,,2023-12-29T05:00:00Z,2023,12,2023-12-29T05:00:00Z,2024-01-30T04:59:59Z,2024-01-30T02:00:37Z,2023-28719,0,0,0900006486365625
EPA-HQ-OA-2013-0320-0031,EPA,EPA-HQ-OA-2013-0320,Guidance: Assessing Environmental Justice in Regulatory Analysis,Notice,Extension of Comment Period,2023-12-28T05:00:00Z,2023,12,,,2023-12-28T15:37:42Z,2023-28598,0,0,0900006486361790
EPA-HQ-OW-2015-0680-0423,EPA,EPA-HQ-OW-2015-0680,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Use of Lead Free Pipes, Fittings, Fixtures, Solder and Flux for Drinking Water (Renewal)",Notice,,2023-12-28T05:00:00Z,2023,12,2023-12-28T05:00:00Z,2024-01-30T04:59:59Z,2023-12-28T15:01:47Z,2023-28640,0,0,0900006486361660
EPA-HQ-OLEM-2023-0244-0002,EPA,EPA-HQ-OLEM-2023-0244,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Disposal of Coal Combustion Residuals From Electric Utilities (Renewal)",Notice,,2023-12-28T05:00:00Z,2023,12,2023-12-28T05:00:00Z,2024-01-30T04:59:59Z,2023-12-28T15:15:36Z,2023-28639,0,0,090000648636172c
EPA-HQ-OW-2017-0300-1915,EPA,EPA-HQ-OW-2017-0300,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Lead and Copper Rule Revisions",Notice,,2023-12-28T05:00:00Z,2023,12,2023-12-28T05:00:00Z,2024-01-30T04:59:59Z,2023-12-28T15:24:27Z,2023-28641,0,0,0900006486361915
EPA-HQ-OPPT-2015-0436-0042,EPA,EPA-HQ-OPPT-2015-0436,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Generic Clearance for TSCA Section 4 Test Rules, Test Orders, Enforceable Consent Agreements, Voluntary Data Submissions, and Exemptions From Testing Requirements (Renewal)",Notice,,2023-12-28T05:00:00Z,2023,12,2023-12-28T05:00:00Z,2024-01-30T04:59:59Z,2023-12-28T15:09:11Z,2023-28663,0,0,09000064863616e9
FDA-2021-N-0039-0002,FDA,FDA-2021-N-0039,"Electronic Submissions; Update to the Specifications for Preparing and
Submitting Postmarket Individual Case Safety Reports for Vaccines; Technical
Specification",Notice,Notice of Availability,2023-12-28T05:00:00Z,2023,12,2023-12-28T05:00:00Z,,2024-11-12T06:21:06Z,2023-28594,1,0,090000648636182b
FDA-2023-D-4177-0021,FDA,FDA-2023-D-4177,Quality Considerations for Topical Ophthalmic Drug Products; Revised Draft Guidance for Industry; Availability,Notice,Notice of Availability,2023-12-28T05:00:00Z,2023,12,2023-12-28T05:00:00Z,,2023-12-28T15:10:09Z,2023-28595,0,0,090000648636165b
FDA-2023-D-4299-0001,FDA,FDA-2023-D-4299,Potency Assurance for Cellular and Gene Therapy Products; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2023-12-28T05:00:00Z,2023,12,2023-12-28T05:00:00Z,,2023-12-28T16:34:21Z,2023-28596,0,0,090000648636182c
FDA-2023-D-5408-0001,FDA,FDA-2023-D-5408,Reformulating Drug Products That Contain Carbomers Manufactured With Benzene; Guidance for Industry; Availability,Notice,Notice of Availability,2023-12-28T05:00:00Z,2023,12,2023-12-28T05:00:00Z,,2023-12-28T16:02:50Z,2023-28675,0,0,090000648636165e
USDA_FRDOC_0001-2953,USDA,USDA_FRDOC_0001,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,,2023-12-28T05:00:00Z,2023,12,2023-12-28T05:00:00Z,,2023-12-28T13:31:28Z,2023-28576,0,0,090000648636165c
USDA-2022-0010-0002,USDA,USDA-2022-0010,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Funding Opportunity",Notice,,2023-12-28T05:00:00Z,2023,12,2023-12-28T05:00:00Z,2024-02-27T04:59:59Z,2024-06-05T13:16:38Z,2023-28571,0,0,09000064863616ae
APHIS-2023-0022-3038,APHIS,APHIS-2023-0022,Exemption: Movement of Organisms Modified or Produced through Genetic Engineering,Notice,Availability of Document,2023-12-27T05:00:00Z,2023,12,,,2023-12-28T14:11:52Z,2023-28545,0,0,090000648635c4e3
EPA-HQ-OPP-2023-0074-0006,EPA,EPA-HQ-OPP-2023-0074,Cancellation Order for Certain Pesticide Registrations and Amendments to Terminate Uses,Notice,,2023-12-27T05:00:00Z,2023,12,2023-12-27T05:00:00Z,,2023-12-27T21:20:01Z,2023-28547,0,0,090000648635c583
EPA-HQ-OPP-2023-0075-0006,EPA,EPA-HQ-OPP-2023-0075,Product Cancellation Order for Certain Pesticide Registrations,Notice,,2023-12-27T05:00:00Z,2023,12,2023-12-27T05:00:00Z,,2023-12-27T17:08:40Z,2023-28557,0,0,090000648635c4e5
FDA-2022-E-0931-0005,FDA,FDA-2022-E-0931,Determination of Regulatory Review Period for Purposes of Patent Extension; ZOKINVY,Notice,Determinations,2023-12-27T05:00:00Z,2023,12,2023-12-27T05:00:00Z,2024-06-25T03:59:59Z,2024-06-25T01:00:33Z,2023-28511,0,0,090000648635c4ea
FDA-2023-F-5500-0001,FDA,FDA-2023-F-5500,"Kemin Industries, Inc.; Filing of Food Additive Petition (Animal Use); Chromium Propionate; Correction.",Notice,Correction,2023-12-27T05:00:00Z,2023,12,2023-12-27T05:00:00Z,,2023-12-29T15:38:50Z,2023-28512,0,0,090000648635c3a9
FDA-2023-F-2415-0004,FDA,FDA-2023-F-2415,"Kemin Industries, Inc.; Filing of Food Additive Petition (Animal Use); Chromium Propionate; Correction.",Notice,Correction,2023-12-27T05:00:00Z,2023,12,2023-12-27T05:00:00Z,,2023-12-29T15:48:26Z,2023-28512,0,0,090000648635d693
FDA-2022-E-0936-0005,FDA,FDA-2022-E-0936,Determination of Regulatory Review Period for Purposes of Patent Extension; ZOKINVY,Notice,Determinations,2023-12-27T05:00:00Z,2023,12,2023-12-27T05:00:00Z,2024-06-25T03:59:59Z,2023-12-27T15:24:10Z,2023-28511,0,0,090000648635c012
FDA-2022-E-2225-0005,FDA,FDA-2022-E-2225,Determination of Regulatory Review Period for Purposes of Patent Extension; SCEMBLIX,Notice,Determinations,2023-12-27T05:00:00Z,2023,12,2023-12-27T05:00:00Z,2024-06-25T03:59:59Z,2023-12-27T14:50:39Z,2023-28519,0,0,090000648635c3e9
FDA-2022-E-2035-0004,FDA,FDA-2022-E-2035,Determination of Regulatory Review Period for Purposes of Patent Extension; PONVORY,Notice,Determinations,2023-12-27T05:00:00Z,2023,12,2023-12-27T05:00:00Z,2024-06-25T03:59:59Z,2023-12-27T15:44:15Z,2023-28509,0,0,090000648635c5cc
FDA-2022-E-0926-0005,FDA,FDA-2022-E-0926,Determination of Regulatory Review Period for Purposes of Patent Extension; CYTALUX,Notice,Determinations,2023-12-27T05:00:00Z,2023,12,2023-12-27T05:00:00Z,2024-06-25T03:59:59Z,2024-06-15T01:00:26Z,2023-28507,0,0,090000648635c493
FWS-HQ-IA-2023-0253-0001,FWS,FWS-HQ-IA-2023-0253,Foreign Endangered Species; Receipt of Permit Applications,Notice,,2023-12-27T05:00:00Z,2023,12,2023-12-27T05:00:00Z,2024-01-27T04:59:59Z,2024-01-27T02:00:33Z,2023-28470,0,0,090000648635ae7f
USDA_FRDOC_0001-2952,USDA,USDA_FRDOC_0001,"Hearings, Meetings, Proceedings, etc.: Codex Committee on Food Hygiene",Notice,,2023-12-27T05:00:00Z,2023,12,2023-12-27T05:00:00Z,,2023-12-27T13:22:10Z,2023-28533,0,0,090000648635c5c3
EPA-HQ-OLEM-2023-0451-0001,EPA,EPA-HQ-OLEM-2023-0451,Waste Reduction Model (WARM) Version 16,Notice,,2023-12-26T05:00:00Z,2023,12,2023-12-26T05:00:00Z,2024-02-10T04:59:59Z,2024-02-17T02:00:59Z,2023-28342,0,0,0900006486359866
EPA-HQ-OPPT-2023-0312-0001,EPA,EPA-HQ-OPPT-2023-0312,"4,4′-Methylene bis(2-chloroaniline); Request Under the Toxic Substances Control Act (TSCA) for Records and Reports of Significant Adverse Reactions to Health or the Environment",Notice,,2023-12-26T05:00:00Z,2023,12,2023-12-26T05:00:00Z,,2023-12-26T13:49:05Z,2023-28299,0,0,0900006486359e19
EPA-HQ-OPP-2023-0474-0016,EPA,EPA-HQ-OPP-2023-0474,Endocrine Disruptor Screening Program: Near-Term Strategies for Implementation; Correction,Notice,,2023-12-26T05:00:00Z,2023,12,2023-12-26T05:00:00Z,,2023-12-27T16:56:55Z,2023-28510,0,0,0900006486359e9b
EPA-HQ-OPPT-2023-0351-0001,EPA,EPA-HQ-OPPT-2023-0351,Definition of Lead-Based Paint Joint Virtual Workshop; Notice of Public Meeting and Request for Comments,Notice,Meeting,2023-12-26T05:00:00Z,2023,12,2023-12-26T05:00:00Z,2024-07-01T03:59:59Z,2024-07-01T01:01:01Z,2023-14682,0,0,0900006485c8bdc2
EPA-HQ-OAR-2023-0292-0001,EPA,EPA-HQ-OAR-2023-0292,"Hearings, Meetings, Proceedings, etc.: California State Motor Vehicle Pollution Control Standards; Advanced Clean Cars II Regulations; Request for Waiver of Preemption",Notice,,2023-12-26T05:00:00Z,2023,12,2023-12-26T05:00:00Z,2024-02-28T04:59:59Z,2024-06-12T01:01:02Z,2023-28301,0,0,09000064863598dd
EPA-HQ-OPPT-2023-0613-0001,EPA,EPA-HQ-OPPT-2023-0613,Formaldehyde; Draft Risk Evaluation Peer Review by the Science Advisory Committee on Chemicals (SACC); Request for Nominations of ad hoc Expert Reviewers,Notice,Request for Nominations,2023-12-26T05:00:00Z,2023,12,2023-12-26T05:00:00Z,,2023-12-26T13:40:58Z,2023-28430,0,0,09000064863598a5
EPA-HQ-OPPT-2017-0127-0005,EPA,EPA-HQ-OPPT-2017-0127,"2023 Report; Inventory of Mercury Supply, Use, and Trade in the United States; Notice of Availability",Notice,Notice of Data Availability,2023-12-26T05:00:00Z,2023,12,2023-12-26T05:00:00Z,,2023-12-26T13:55:13Z,2023-28376,0,0,0900006486359f22
FDA-2015-D-2818-0044,FDA,FDA-2015-D-2818,"Rare Diseases: Considerations for the Development of Drugs and Biological
Products; Guidance for Industry; Availability",Notice,Notice of Availability,2023-12-26T05:00:00Z,2023,12,2023-12-26T05:00:00Z,,2023-12-26T14:43:28Z,2023-28310,0,0,0900006486359d43
FWS-R7-ES-2023-0209-0001,FWS,FWS-R7-ES-2023-0209,Proposed Incidental Harassment Authorization for the Southern Beaufort Sea Stock of Polar Bears on the North Slope of Alaska,Notice,,2023-12-26T05:00:00Z,2023,12,2023-12-26T05:00:00Z,2024-01-26T04:59:59Z,2024-02-06T02:00:38Z,2023-28428,0,0,0900006486359708
USDA_FRDOC_0001-2949,USDA,USDA_FRDOC_0001,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,,2023-12-26T05:00:00Z,2023,12,2023-12-26T05:00:00Z,,2023-12-26T13:20:54Z,2023-28379,0,0,0900006486359754
USDA_FRDOC_0001-2950,USDA,USDA_FRDOC_0001,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,,2023-12-26T05:00:00Z,2023,12,2023-12-26T05:00:00Z,,2023-12-26T13:22:12Z,2023-28334,0,0,0900006486359d70
EPA-HQ-OPPT-2023-0061-0027,EPA,EPA-HQ-OPPT-2023-0061,Certain New Chemicals: Status Information for November 2023,Notice,,2023-12-22T05:00:00Z,2023,12,2023-12-22T05:00:00Z,2024-01-23T04:59:59Z,2023-12-25T02:00:16Z,2023-28240,0,0,0900006486351183
EPA-HQ-OPPT-2003-0004-0142,EPA,EPA-HQ-OPPT-2003-0004,Access to Confidential Business Information by CGI Federal Inc.,Notice,,2023-12-22T05:00:00Z,2023,12,2023-12-22T05:00:00Z,,2024-03-15T18:59:22Z,2023-28172,0,0,0900006486351112
EPA-HQ-OPP-2023-0476-0001,EPA,EPA-HQ-OPP-2023-0476,Pesticide Registration: Establishment of the Vector Expedited Review Voucher Program,Notice,,2023-12-22T05:00:00Z,2023,12,2023-12-22T05:00:00Z,,2023-12-22T16:07:09Z,2023-28211,0,0,09000064863512a3
EPA_FRDOC_0001-30317,EPA,EPA_FRDOC_0001,"Environmental Impact Statements; Availability, etc.",Notice,,2023-12-22T05:00:00Z,2023,12,2023-12-22T05:00:00Z,,2023-12-22T13:12:30Z,2023-28249,0,0,0900006486351219
FDA-2023-N-2986-0003,FDA,FDA-2023-N-2986,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,Notice of Approval,2023-12-22T05:00:00Z,2023,12,,,2024-01-08T13:21:53Z,2023-28290,0,0,0900006486351613
FDA-1997-D-0444-0037,FDA,FDA-1997-D-0444,"Special Considerations, Incentives, and Programs To Support the Approval of New Animal Drugs for Minor Uses and for Minor Species; Guidance for Industry; Availability",Notice,Notice of Availability,2023-12-22T05:00:00Z,2023,12,,,2023-12-22T15:18:01Z,2023-28287,0,0,090000648635114c
FDA-2023-D-5259-0001,FDA,FDA-2023-D-5259,Master Protocols for Drug and Biological Product Development; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2023-12-22T05:00:00Z,2023,12,,,2023-12-22T15:36:56Z,2023-28210,0,0,0900006486351218
FDA-2023-N-1157-0004,FDA,FDA-2023-N-1157,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,Notice of Approval,2023-12-22T05:00:00Z,2023,12,,,2024-01-04T22:17:54Z,2023-28290,0,0,0900006486351117
FDA-2013-N-1119-0018,FDA,FDA-2013-N-1119,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,Notice of Approval,2023-12-22T05:00:00Z,2023,12,,,2024-01-08T13:21:11Z,2023-28290,0,0,0900006486351612
FDA-2020-N-0908-0008,FDA,FDA-2020-N-0908,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,Notice of Approval,2023-12-22T05:00:00Z,2023,12,,,2024-01-08T13:14:23Z,2023-28290,0,0,0900006486351564
FDA-2022-D-0814-0008,FDA,FDA-2022-D-0814,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,Notice of Approval,2023-12-22T05:00:00Z,2023,12,,,2024-01-08T13:15:19Z,2023-28290,0,0,0900006486351565
FDA-2019-E-3287-0004,FDA,FDA-2019-E-3287,Determination of Regulatory Review Period for Purposes of Patent Extension; Copiktra,Notice,Determinations,2023-12-22T05:00:00Z,2023,12,2023-12-22T05:00:00Z,2024-02-21T04:59:59Z,2023-12-22T15:41:59Z,2023-28244,0,0,090000648635121b
FDA-2021-D-0548-0036,FDA,FDA-2021-D-0548,"Data Standards for Drug and Biological Product Submissions Containing Real-World Data; Guidance for Industry;
Availability",Notice,Notice of Availability,2023-12-22T05:00:00Z,2023,12,,,2023-12-22T15:08:44Z,2023-28291,0,0,0900006486351145
FDA-2019-E-3017-0004,FDA,FDA-2019-E-3017,Determination of Regulatory Review Period for Purposes of Patent Extension; Emgality,Notice,Determinations,2023-12-22T05:00:00Z,2023,12,2023-12-22T05:00:00Z,2024-02-21T04:59:59Z,2023-12-22T14:20:59Z,2023-28233,0,0,0900006486351116
FDA-2023-N-1189-0004,FDA,FDA-2023-N-1189,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,Notice of Approval,2023-12-22T05:00:00Z,2023,12,,,2024-01-08T13:26:13Z,2023-28290,0,0,09000064863516f6
FDA-2023-N-1006-0004,FDA,FDA-2023-N-1006,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,Notice of Approval,2023-12-22T05:00:00Z,2023,12,,,2024-01-08T13:17:34Z,2023-28290,0,0,090000648635160e
FDA-2021-D-1128-0065,FDA,FDA-2021-D-1128,"Digital Health Technologies for Remote Data Acquisition in Clinical Investigations; Guidance for Industry, Investigators, and Other Stakeholders; Availability",Notice,Notice of Availability,2023-12-22T05:00:00Z,2023,12,,,2023-12-22T15:30:51Z,2023-28262,0,0,0900006486351187
FDA-2023-N-1661-0002,FDA,FDA-2023-N-1661,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,Notice of Approval,2023-12-22T05:00:00Z,2023,12,,,2024-01-08T13:20:18Z,2023-28290,0,0,0900006486351611
FDA-2023-N-1272-0005,FDA,FDA-2023-N-1272,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,Notice of Approval,2023-12-22T05:00:00Z,2023,12,,,2024-01-08T13:24:27Z,2023-28290,0,0,0900006486351615
FDA-2022-D-0745-0014,FDA,FDA-2022-D-0745,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,Notice of Approval,2023-12-22T05:00:00Z,2023,12,,,2024-01-08T13:16:39Z,2023-28290,0,0,090000648635160d
FDA-2023-N-2286-0003,FDA,FDA-2023-N-2286,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,Notice of Approval,2023-12-22T05:00:00Z,2023,12,,,2024-01-08T13:19:03Z,2023-28290,0,0,0900006486351610
FDA-2023-N-2030-0005,FDA,FDA-2023-N-2030,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,Notice of Approval,2023-12-22T05:00:00Z,2023,12,,,2024-01-08T13:25:22Z,2023-28290,0,0,0900006486351616
FDA-2022-D-0109-0016,FDA,FDA-2022-D-0109,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,Notice of Approval,2023-12-22T05:00:00Z,2023,12,,,2024-01-08T13:13:11Z,2023-28290,0,0,0900006486351562
FDA-2021-D-1146-0042,FDA,FDA-2021-D-1146,Real-World Data: Assessing Registries To Support Regulatory Decision-Making for Drug and Biological Products; Guidance for Industry; Availability,Notice,Notice of Availability,2023-12-22T05:00:00Z,2023,12,,,2023-12-22T15:24:04Z,2023-28289,0,0,090000648635117e
FDA-2009-N-0582-0129,FDA,FDA-2009-N-0582,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,Notice of Approval,2023-12-22T05:00:00Z,2023,12,,,2024-01-08T13:23:07Z,2023-28290,0,0,0900006486351614
FDA-2023-N-1053-0004,FDA,FDA-2023-N-1053,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,Notice of Approval,2023-12-22T05:00:00Z,2023,12,,,2024-01-08T13:18:22Z,2023-28290,0,0,090000648635160f
USDA_FRDOC_0001-2948,USDA,USDA_FRDOC_0001,"Hearings, Meetings, Proceedings etc.: Codex Alimentarius Commission, Committee on Fats and Oils",Notice,,2023-12-22T05:00:00Z,2023,12,2023-12-22T05:00:00Z,,2023-12-22T13:12:16Z,2023-28269,0,0,09000064863511c8
USDA_FRDOC_0001-2947,USDA,USDA_FRDOC_0001,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,,2023-12-22T05:00:00Z,2023,12,2023-12-22T05:00:00Z,,2023-12-22T13:12:01Z,2023-28171,0,0,090000648635114b
EPA-HQ-OPP-2019-0188-0005,EPA,EPA-HQ-OPP-2019-0188,RTI International and ToxStrategies LLC; Transfer of Data (December 2023),Notice,,2023-12-21T05:00:00Z,2023,12,2023-12-21T05:00:00Z,,2023-12-21T17:44:20Z,2023-28088,0,0,090000648634dc43
FDA-2022-E-2013-0004,FDA,FDA-2022-E-2013,Determination of Regulatory Review Period for Purposes of Patent Extension; LYBALV,Notice,Determinations,2023-12-21T05:00:00Z,2023,12,2023-12-21T05:00:00Z,2024-02-21T04:59:59Z,2023-12-21T14:39:34Z,2023-28094,0,0,090000648634dc9c
FDA-2022-E-2011-0004,FDA,FDA-2022-E-2011,Determination of Regulatory Review Period for Purposes of Patent Extension; LYBALV,Notice,Determinations,2023-12-21T05:00:00Z,2023,12,2023-12-21T05:00:00Z,2024-02-21T04:59:59Z,2023-12-21T15:32:46Z,2023-28094,0,0,090000648634e3d5
FDA-2022-E-2012-0004,FDA,FDA-2022-E-2012,Determination of Regulatory Review Period for Purposes of Patent Extension; LYBALV,Notice,Determinations,2023-12-21T05:00:00Z,2023,12,2023-12-21T05:00:00Z,2024-02-21T04:59:59Z,2023-12-21T15:40:37Z,2023-28094,0,0,090000648634e3d6
FDA-2022-E-2010-0004,FDA,FDA-2022-E-2010,Determination of Regulatory Review Period for Purposes of Patent Extension; LYBALV,Notice,Determinations,2023-12-21T05:00:00Z,2023,12,2023-12-21T05:00:00Z,2024-02-21T04:59:59Z,2023-12-21T15:29:45Z,2023-28094,0,0,090000648634e3d4
FDA-2020-D-1136-0084,FDA,FDA-2020-D-1136,"Development of Monoclonal Antibody Products Targeting SARS–CoV–2 for
Emergency Use Authorization; Guidance for Industry; Availability",Notice,Notice of Availability,2023-12-21T05:00:00Z,2023,12,,,2023-12-21T16:06:18Z,2023-28092,0,0,090000648634e184
FDA-2016-D-2565-0029,FDA,FDA-2016-D-2565,"510(k) Third Party Review Program and Third Party Emergency Use
Authorization (EUA) Review; Draft Guidance for Industry, Food and Drug
Administration Staff, and Third Party Review Organizations; Availability",Notice,Notice of Availability,2023-12-21T05:00:00Z,2023,12,,,2023-12-21T17:23:07Z,2023-28095,0,0,090000648634e286
FDA-2022-E-2009-0004,FDA,FDA-2022-E-2009,Determination of Regulatory Review Period for Purposes of Patent Extension; LYBALV,Notice,Determinations,2023-12-21T05:00:00Z,2023,12,2023-12-21T05:00:00Z,2024-02-21T04:59:59Z,2023-12-21T15:26:24Z,2023-28094,0,0,090000648634e3d3
FDA-2023-N-4201-0001,FDA,FDA-2023-N-4201,Agency Information Collection Activities; Proposed Collection; Comment Request; Examination of Implied Claims in Direct-to-Consumer Prescription Drug Promotion,Notice,60 Day Proposed Information Collection,2023-12-21T05:00:00Z,2023,12,2023-12-21T05:00:00Z,2024-02-21T04:59:59Z,2024-02-21T02:00:37Z,2023-28093,0,0,090000648634dc45
USDA_FRDOC_0001-2946,USDA,USDA_FRDOC_0001,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,,2023-12-21T05:00:00Z,2023,12,2023-12-21T05:00:00Z,,2023-12-21T13:45:06Z,2023-28086,0,0,090000648634e232
FDA-2023-N-5020-0001,FDA,FDA-2023-N-5020,"Notice to Public of Website Location of the Office of the Chief Scientist
Proposed Guidance Development List",Notice,General Notice,2023-12-20T05:00:00Z,2023,12,2023-12-20T05:00:00Z,,2025-01-24T02:01:16Z,2023-27967,1,0,090000648634bbbc
USDA_FRDOC_0001-2945,USDA,USDA_FRDOC_0001,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,,2023-12-20T05:00:00Z,2023,12,2023-12-20T05:00:00Z,,2023-12-20T13:25:56Z,2023-27888,0,0,090000648634ba38
EPA-R09-OW-2023-0623-0006,EPA,EPA-R09-OW-2023-0623,CTV I 26R Public Notice (Spanish),Notice,,2023-12-19T05:00:00Z,2023,12,2023-12-19T05:00:00Z,2024-03-21T03:59:59Z,2024-08-03T19:46:07Z,,0,0,09000064863483a0
EPA-HQ-OPP-2023-0070-0009,EPA,EPA-HQ-OPP-2023-0070,Pesticide Product Registration: Applications for New Active Ingredients,Notice,,2023-12-19T05:00:00Z,2023,12,,,2023-12-19T15:23:49Z,2023-27773,0,0,0900006486346c1f
EPA_FRDOC_0001-30302,EPA,EPA_FRDOC_0001,"Hearings, Meetings, Proceedings etc.: Science Advisory Board Inorganic Arsenic Review Panel",Notice,,2023-12-19T05:00:00Z,2023,12,2023-12-19T05:00:00Z,,2023-12-19T13:21:40Z,2023-27828,0,0,0900006486346c21
EPA-HQ-OPP-2023-0557-0001,EPA,EPA-HQ-OPP-2023-0557,Pesticide Product Registration: Applications for New Active Ingredients,Notice,,2023-12-19T05:00:00Z,2023,12,2023-12-19T05:00:00Z,2024-01-19T04:59:59Z,2024-01-17T02:00:33Z,2023-27773,0,0,09000064863470a1
EPA-R09-OW-2023-0623-0005,EPA,EPA-R09-OW-2023-0623,CTV I 26R Public Notice (English),Notice,,2023-12-19T05:00:00Z,2023,12,2023-12-19T05:00:00Z,2024-03-21T03:59:59Z,2024-08-03T23:24:44Z,,0,0,090000648634839f
EPA-HQ-OPP-2023-0558-0001,EPA,EPA-HQ-OPP-2023-0558,Pesticide Product Registration: Applications for New Active Ingredients,Notice,,2023-12-19T05:00:00Z,2023,12,2023-12-19T05:00:00Z,2024-01-19T04:59:59Z,2024-02-08T02:00:52Z,2023-27773,0,0,090000648634724f
FDA-2023-D-1716-0053,FDA,FDA-2023-D-1716,Registration and Listing of Cosmetic Product Facilities and Products; Guidance for Industry; Availability,Notice,Notice of Availability,2023-12-19T05:00:00Z,2023,12,2023-12-19T05:00:00Z,,2023-12-19T15:33:24Z,2023-27649,0,0,0900006486346b66
FDA-2023-P-4596-0004,FDA,FDA-2023-P-4596,"Determination That MEPHYTON (Phytonadione) Tablets, 5 Milligrams, Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,Determinations,2023-12-19T05:00:00Z,2023,12,2023-12-19T05:00:00Z,,2023-12-19T16:46:30Z,2023-27858,0,0,0900006486346c55
FDA-2023-N-5431-0001,FDA,FDA-2023-N-5431,"Hospira, Inc., et al.; Withdrawal of Approval of Eight Abbreviated New Drug Applications",Notice,Withdrawal,2023-12-19T05:00:00Z,2023,12,2023-12-19T05:00:00Z,,2023-12-19T16:19:50Z,2023-27853,0,0,0900006486346be7
FDA-2023-D-4395-0001,FDA,FDA-2023-D-4395,"Use of Real-World Evidence To Support Regulatory Decision-Making for Medical Devices, Draft Guidance for Industry and Food and Drug Administration Staff; Availability",Notice,Notice of Availability,2023-12-19T05:00:00Z,2023,12,2023-12-19T05:00:00Z,,2023-12-19T16:31:03Z,2023-27852,0,0,0900006486346c20
FDA-2023-N-2080-0002,FDA,FDA-2023-N-2080,Jeremy Walenty: Final Debarment Order,Notice,Statutory Debarment,2023-12-19T05:00:00Z,2023,12,2023-12-19T05:00:00Z,2023-12-20T04:59:59Z,2024-11-12T06:22:14Z,2023-27855,1,0,0900006486346be3
FDA-2009-N-0026-0005,FDA,FDA-2009-N-0026,"Apothecon, et al.; Withdrawal of Approval of 103 New Drug Applications and 35 Abbreviated New Drug Applications; Correction",Notice,Correction,2023-12-19T05:00:00Z,2023,12,2023-12-19T05:00:00Z,,2023-12-19T15:58:07Z,2023-27859,0,0,0900006486346ba5
FDA-2023-N-2058-0002,FDA,FDA-2023-N-2058,James Funaro: Final Debarment Order,Notice,Statutory Debarment,2023-12-19T05:00:00Z,2023,12,2023-12-19T05:00:00Z,2023-12-20T04:59:59Z,2024-11-12T06:22:13Z,2023-27854,1,0,0900006486346ba7
USDA_FRDOC_0001-2944,USDA,USDA_FRDOC_0001,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,,2023-12-19T05:00:00Z,2023,12,2023-12-19T05:00:00Z,,2023-12-19T13:21:37Z,2023-27845,0,0,0900006486346c1e
EPA-HQ-OPPT-2023-0601-0002,EPA,EPA-HQ-OPPT-2023-0601,Initiation of Prioritization Under the Toxic Substances Control Act (TSCA),Notice,,2023-12-18T05:00:00Z,2023,12,2023-12-18T05:00:00Z,2024-03-19T03:59:59Z,2024-04-09T01:00:51Z,2023-27641,0,0,090000648634394a
FDA-2023-N-5344-0001,FDA,FDA-2023-N-5344,"Pharmacyclics LLC.; Withdrawal of Approval of Indications for Mantle Cell Lymphoma and Marginal Zone
Lymphoma for IMBRUVICA (ibrutinib) Capsules and Tablets",Notice,Withdrawal,2023-12-18T05:00:00Z,2023,12,2023-12-18T05:00:00Z,,2023-12-18T14:30:13Z,2023-27662,0,0,09000064863439f9
FDA-2023-D-3740-0001,FDA,FDA-2023-D-3740,Priority Zoonotic Animal Drug Designation and Review Process; Draft Guidance for Industry; Availability,Notice,Notice of Availability,2023-12-18T05:00:00Z,2023,12,2023-12-18T05:00:00Z,,2023-12-18T14:17:53Z,2023-27655,0,0,0900006486343903
FDA-2023-N-5323-0001,FDA,FDA-2023-N-5323,"Hoffmann-La Roche, Inc., et al.; Withdrawal of Approval of Two New Drug Applications",Notice,Withdrawal,2023-12-18T05:00:00Z,2023,12,2023-12-18T05:00:00Z,,2023-12-18T14:31:47Z,2023-27661,0,0,0900006486343a3b
FDA-2023-N-0795-0007,FDA,FDA-2023-N-0795,"Agency Information Collection Activities; Submission for Office of Management and Budget Review;
Comment Request; A Survey on Quantitative Claims in Direct-to-Consumer Prescription Drug Advertising",Notice,30 Day Proposed Information Collection,2023-12-18T05:00:00Z,2023,12,2023-12-18T05:00:00Z,2024-01-18T04:59:59Z,2024-01-17T02:00:34Z,2023-27652,0,0,090000648634394b
FWS-R4-ES-2023-0198-0005,FWS,FWS-R4-ES-2023-0198,"Three Incidental Permit Applications and Proposed Habitat Conservation Plans; Lake, Volusia, and Orange Counties, FL; Reopening of Comment Periods",Notice,,2023-12-18T05:00:00Z,2023,12,2023-12-08T05:00:00Z,2024-01-09T04:59:59Z,2023-12-18T21:06:36Z,,0,0,0900006486344731
FWS-R4-ES-2023-0194-0007,FWS,FWS-R4-ES-2023-0194,"Three Incidental Permit Applications and Proposed Habitat Conservation Plans; Lake, Volusia, and Orange Counties, FL; Reopening of Comment Periods",Notice,,2023-12-18T05:00:00Z,2023,12,2023-12-18T05:00:00Z,2024-01-09T04:59:59Z,2023-12-18T21:08:17Z,2023-26977,0,0,0900006486344732
FWS-R4-ES-2023-0193-0005,FWS,FWS-R4-ES-2023-0193,"Three Incidental Permit Applications and Proposed Habitat Conservation Plans; Lake, Volusia, and Orange Counties, FL; Reopening of Comment Periods",Notice,,2023-12-18T05:00:00Z,2023,12,2023-12-18T05:00:00Z,2024-01-09T04:59:59Z,2024-01-09T02:01:17Z,2023-26977,0,0,0900006486344739